Platelets, key facilitators of primary hemostasis and thrombosis, have emerged as crucial
cellular mediators of innate immunity and inflammation. Exemplified by their ability to alter …

The pathological mechanism of neuropathic pain is complex, which seriously affects the
physical and mental health of patients, and its treatment is also difficult. The role of G protein …

Kawasaki disease (KD) is the leading cause of acquired heart disease among children.
Increased platelet counts and activation are observed during the course of KD, and elevated …

Importance Platelet activation is a potential therapeutic target in patients with COVID-19.
Objective To evaluate the effect of P2Y12 inhibition among critically ill patients hospitalized …

The authors investigated the impact of antiplatelet therapy on the megakaryocyte (MK) and
platelet transcriptome. RNA-sequencing was performed on MKs treated with aspirin or …

Kawasaki disease, a systemic vasculitis that affects young children and can result in
coronary artery aneurysms, is the leading cause of acquired heart disease among children …

Haemostasis join forces in a collaborative editorial to share and emphasize our commitment
to advancing research, education, and clinical practice, and reducing the impact of …

Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious
pulmonary vascular disease characterized by residual thrombi in the pulmonary arteries and …

Nanomaterials have been extensively used in the biomedical field due to their unique
physical and chemical properties. They promise wide applications in the diagnosis …

Targeting microRNAs is a promising therapeutic approach to control thrombosis in patients
with both infectious and noninfectious inflammatory diseases. Future research efforts should …